Mark Bathe

Co-founder at Kano Therapeutics

Mark Bathe is a Professor at MIT, with a focus on engineering nucleic acids for targeted delivery of therapeutics and vaccines, phenotypic profiling of neuronal circuits, and molecular computing. Mark is also a SIY Certified Teacher at Search Inside Yourself Leadership Institute, Director of MIT's New Engineering Education Transformation program, and a Co-Founder at Cache DNA and Kano Therapeutics. In addition, Mark is a member of the HMS Initiative for RNA Medicine at Harvard Medical School and an Associate Member at the Broad Institute of MIT & Harvard. With a background in Mechanical Engineering from MIT, Mark has a strong foundation in various interdisciplinary fields.

Links

Timeline

  • Co-founder

    January, 2022 - present